Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

UV PROTECTIVE COMPACT FOUNDATION (REFILL) - Health Canada Drug Approval Details

Approvals/Health Canada/UV PROTECTIVE COMPACT FOUNDATION (REFILL)

Authorized

STANDARD

UV PROTECTIVE COMPACT FOUNDATION (REFILL)

shiseido americas corporation dist🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 2bf56fd7bc030bfc
Company: shiseido americas corporation dist
Type: Standard

Approval Details

Approval Id: 2bf56fd7bc030bfc
Drug Approval Canada Name: UV PROTECTIVE COMPACT FOUNDATION (REFILL)
Product Name: UV PROTECTIVE COMPACT FOUNDATION (REFILL)
Status: Cancelled Post Market
Status Date: 2019-08-07
Original Market Date: 2016-03-14
Din: 02424002
Drug Class: Human
Dosage Form: Powder
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:80.00
Atc Original: D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name: d 02 ba 30
Aig Number: 0324027015
Company Name: shiseido americas corporation dist
Company Address: 900 Third Avenue, New York, New York, United States, 10017

Active Ingredients

OCTINOXATE

7.4 % / W/W

OCTOCRYLENE

5 % / W/W

TITANIUM DIOXIDE

11.8 % / W/W

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2bf56fd7bc030bfc

Type

Standard

Back to Health Canada Approvals